A Clinical Trial to Evaluate the Safety of agenT-797 in COVID-19 Participants With ARDS
NCT04582201
Lung Diseases, Respiration Disorders
Santa Monica, California, United States
View Trial DetailsNCT Number: NCT01256333
Despite improving in the treatment of acute respiratory distress syndrome (ARDS), this affection keep an elevate rate of death. The strategy of mechanical ventilation is more and more under definite protocol, following large strength randomized studies. Although, it doesn't exist today element allowing to adjust the level of Positive End-Expiratory Pressure (PEEP) with improvement in patient's survival.
The investigators proposed in this study to determinate the level of PEEP adjust to obtain the better arterial oxygen transport (TaO2). The investigators going to conduct a physiologic, observational, none controlled study. All patients hospitalized in intensive care unit of Pontchaillou hospital with ARDS criteria and without specific exclusion criteria will be included. Primary objective is to looking for the optimum level of PEEP for TaO2.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Perigueux Hospital, Périgueux, Aquitaine, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 year
Time frame: 1 year
Time frame: 1 year
Time frame: 1 year
Time frame: 1 year
Rennes University Hospital
Other
Acronym: OPTIPEP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04582201
Lung Diseases, Respiration Disorders
Santa Monica, California, United States
View Trial DetailsNCT03818854
Lung Diseases, Respiration Disorders
Sacramento, California, United States
View Trial DetailsNCT02273687
Disease Attributes, Emergencies
Nîmes, France
View Trial DetailsNCT01743105
Disease Attributes, Emergencies
Nîmes, Gard, France
View Trial Details